✦ LIBER ✦

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis

✍ Scribed by Park, H.; Park, C.; Kim, Y.; Rascati, K. L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB3 EFFICACY AND SAFETY OF DIPEPTIDYL-P

✍ H Park; YA Kim; KL Rascati 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PDB10 A Meta-Analysis of Efficacy and Sa

✍ H. Park; C. Park; Y. Kim; K.L. Rascati 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Longer term safety of dipeptidyl peptida

✍ K. Gooßen; S. Gräber 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Efficacy and safety of the dipeptidyl pe

✍ J. Rosenstock; A. J. Lewin; P. Norwood; V. Somayaji; T. T. Nguyen; J. G. Teeter; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Dipeptidyl peptidase-4 inhibitors and Hb

✍ K. Esposito; D. Cozzolino; G. Bellastella; M. I. Maiorino; P. Chiodini; A. Cerie 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB